PNC Financial Services Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.5K | Sell |
2,074
-41
| -2% | -$1.3K | ﹤0.01% | 2965 |
|
|
2025
Q1 | $70.2K | Sell |
2,115
-213
| -9% | -$7.07K | ﹤0.01% | 2893 |
|
|
2024
Q4 | $80.1K | Buy |
2,328
+519
| +29% | +$17.9K | ﹤0.01% | 2818 |
|
|
2024
Q3 | $72.4K | Sell |
1,809
-12
| -0.7% | -$480 | ﹤0.01% | 2864 |
|
|
2024
Q2 | $54.9K | Buy |
1,821
+325
| +22% | +$9.81K | ﹤0.01% | 2975 |
|
|
2024
Q1 | $50.2K | Sell |
1,496
-452
| -23% | -$15.2K | ﹤0.01% | 2997 |
|
|
2023
Q4 | $62.9K | Buy |
1,948
+53
| +3% | +$1.71K | ﹤0.01% | 2855 |
|
|
2023
Q3 | $62.1K | Sell |
1,895
-4,723
| -71% | -$155K | ﹤0.01% | 2835 |
|
|
2023
Q2 | $233K | Buy |
6,618
+854
| +15% | +$30.1K | ﹤0.01% | 2099 |
|
|
2023
Q1 | $188K | Buy |
5,764
+1,579
| +38% | +$51.6K | ﹤0.01% | 2178 |
|
|
2022
Q4 | $231K | Buy |
4,185
+3,081
| +279% | +$170K | ﹤0.01% | 2015 |
|
|
2022
Q3 | $49K | Buy |
1,104
+356
| +48% | +$15.8K | ﹤0.01% | 2987 |
|
|
2022
Q2 | $36K | Buy |
748
+401
| +116% | +$19.3K | ﹤0.01% | 3181 |
|
|
2022
Q1 | $17K | Sell |
347
-519
| -60% | -$25.4K | ﹤0.01% | 3647 |
|
|
2021
Q4 | $37K | Buy |
+866
| New | +$37K | ﹤0.01% | 3270 |
|